Bacil Pharma Ltd
₹ 43.4
-1.99%
22 Nov
- close price
- Market Cap ₹ 25.6 Cr.
- Current Price ₹ 43.4
- High / Low ₹ 50.0 / 4.68
- Stock P/E 65.6
- Book Value ₹ 2.87
- Dividend Yield 0.00 %
- ROCE -13.1 %
- ROE -13.8 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 15.1 times its book value
- Promoter holding has decreased over last quarter: -22.0%
- Promoter holding is low: 20.7%
- Company has a low return on equity of -11.3% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.06 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | |
| 1.06 | 0.09 | 0.11 | 0.13 | 0.17 | 0.29 | 0.26 | 0.18 | 0.16 | 0.16 | 0.17 | 0.19 | 0.22 | |
| Operating Profit | -0.00 | -0.09 | -0.11 | -0.13 | -0.17 | -0.29 | -0.26 | -0.18 | -0.16 | -0.16 | -0.17 | -0.19 | -0.22 |
| OPM % | -0.00% | ||||||||||||
| -0.02 | -0.01 | 0.08 | 0.06 | 0.17 | -3.42 | -0.07 | -0.12 | -0.07 | -3.70 | 0.07 | 0.13 | 0.62 | |
| Interest | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.03 | -0.00 | 0.01 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 |
| Depreciation | -0.00 | 0.01 | -0.00 | -0.00 | -0.00 | 0.01 | 0.01 | 0.01 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 |
| Profit before tax | -0.02 | -0.11 | -0.03 | -0.07 | -0.00 | -3.75 | -0.34 | -0.32 | -0.23 | -3.86 | -0.10 | -0.06 | 0.40 |
| Tax % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | ||
| -0.02 | -0.11 | -0.03 | -0.07 | -0.00 | -3.75 | -0.34 | -0.32 | -0.24 | -3.86 | -0.10 | -0.06 | 0.39 | |
| EPS in Rs | -0.03 | -0.19 | -0.05 | -0.12 | -0.00 | -6.37 | -0.58 | -0.54 | -0.41 | -6.55 | -0.17 | -0.10 | 0.66 |
| Dividend Payout % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 2% |
| 3 Years: | -26% |
| TTM: | 455% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 25% |
| 5 Years: | 85% |
| 3 Years: | 107% |
| 1 Year: | 636% |
| Return on Equity | |
|---|---|
| 10 Years: | -4% |
| 5 Years: | -9% |
| 3 Years: | -11% |
| Last Year: | -14% |
Balance Sheet
Figures in Rs. Crores
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6.53 | 6.53 | 6.53 | 6.53 | 6.53 | 6.53 | 6.53 | 6.53 | 6.53 | 6.53 | 6.53 | 6.53 | 6.53 |
| Reserves | 0.08 | -0.03 | -0.06 | -0.13 | -0.09 | -4.29 | -4.62 | -5.14 | -5.14 | -5.30 | -5.43 | -5.31 | -4.84 |
| -0.00 | 0.08 | 0.14 | 0.27 | 0.31 | -0.00 | 0.10 | 0.17 | 0.18 | 0.03 | 0.02 | 0.10 | 0.16 | |
| 0.33 | 0.01 | 0.02 | 0.02 | 0.02 | 2.51 | 2.55 | 2.55 | 2.52 | 0.01 | 0.01 | 0.01 | 0.01 | |
| Total Liabilities | 6.94 | 6.59 | 6.63 | 6.69 | 6.77 | 4.75 | 4.56 | 4.11 | 4.09 | 1.27 | 1.13 | 1.33 | 1.86 |
| 0.01 | 0.01 | 0.01 | 5.25 | 5.94 | 2.53 | 2.53 | 2.52 | 2.51 | 0.01 | 0.01 | 0.01 | -0.00 | |
| CWIP | 5.73 | 5.80 | 5.88 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
| Investments | 0.33 | 0.25 | 0.51 | 0.51 | 0.54 | 1.15 | 0.96 | 0.43 | 0.37 | 0.31 | 0.43 | 0.61 | 0.36 |
| 0.87 | 0.53 | 0.23 | 0.93 | 0.29 | 1.07 | 1.07 | 1.16 | 1.21 | 0.95 | 0.69 | 0.71 | 1.50 | |
| Total Assets | 6.94 | 6.59 | 6.63 | 6.69 | 6.77 | 4.75 | 4.56 | 4.11 | 4.09 | 1.27 | 1.13 | 1.33 | 1.86 |
Cash Flows
Figures in Rs. Crores
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.08 | -0.05 | 0.26 | 0.06 | -0.00 | 1.44 | -0.30 | -0.38 | -0.40 | -4.01 | -0.15 | -0.00 | |
| -0.01 | -0.00 | -0.33 | -0.05 | 0.02 | -1.20 | 0.28 | 0.39 | 0.53 | 3.81 | -0.12 | 0.08 | |
| -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.16 | -0.06 | -0.07 | 0.33 | 0.06 | -0.06 | |
| Net Cash Flow | 0.07 | -0.05 | -0.07 | 0.01 | 0.02 | 0.23 | -0.18 | -0.05 | 0.06 | 0.13 | -0.20 | 0.01 |
Ratios
Figures in Rs. Crores
| Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 3.44 | |||||||||||
| Inventory Days | -0.00 | |||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 3.44 | |||||||||||
| Working Capital Days | 137.74 | |||||||||||
| ROCE % | 0.15% | -0.61% | -0.45% | -1.05% | -1.49% | -6.01% | -8.47% | -2.80% | -5.75% | -7.07% | -12.61% | -13.11% |
Documents
Announcements
-
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
18 Nov - Results of Extra-Ordinary General Meeting held on Nov 14, 2024.
- Shareholder Meeting / Postal Ballot-Outcome of EGM 14 Nov
- Corrigendum To The Notice Of The EOGM Dated 15/10/2024 12 Nov
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 12 Nov
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 11 Nov
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Operational Status:[1]
Company is non operational for the past many years. It has not carried out any major business activity and management is considering diversifying their business activities and have deployed surplus funds as temporary loans and advances